HDAC9 and central nervous system cancer: Furthermore, we found a number of histones and histone deacetylases in our proteomic efforts (Supplementary Tables S1 and S2), with studies suggesting that bortezomib combined with HDAC inhibitors may show efficacy against glioma cells [96].